Atrophy of thyroid (acquired)

E4_ATROTHY

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E03.4
  • Hospital discharge: ICD-9 2448B
  • Cause of death: ICD-10 E03.4
  • Cause of death: ICD-9 2448B

2 out of 7 registries used, show all original rules.

51

4. Check minimum number of events

None

51

5. Include endpoints

None

51

6. Filter based on genotype QC (FinnGen only)

50

Control definitions (FinnGen only)

Control exclude
E4_THYROID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E03
Name in latin
Atrophia glandulae thyreoideae [acquisita]

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 551 413 132
Only index persons 364 274 90
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.00
Only index persons 0.01 0.01 0.00
Median age at first event (years)
Whole population 64.16 64.40 63.12
Only index persons 55.98 56.10 55.62

-FinnGen-

Key figures

All Female Male
Number of individuals 50 43 7
Unadjusted period prevalence (%) 0.01 0.02 0.00
Median age at first event (years) 54.71 53.34 63.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
51
Matched controls
510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03AA01
ATC
levothyroxine sodium; systemic
+∞
64.5
51
7
104
Kela drug reimbursment
Thyroid insufficiency
+∞
41.4
34
*
E03.4
ICD-10 Finland
Atrophy of thyroid (acquired)
+∞
38.5
32
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
232.6
32.0
30
*
2448B
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS ATROPHICANS PRIMARIA]
+∞
21.3
19
*
E03
ICD-10 Finland
Other hypothyroidism
107.0
8.7
9
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
+∞
7.5
7
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
79.4
6.6
7
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
+∞
6.4
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
17
71
3.09
3.22
3.1
2.9
4586.83
25.89
mg/l
—
9
48
17
77
2.81
2.75
3.4
3.4
30.07
3.97
mg/mmol
—
10
48
9
30
3.42
2.28
3.2
2.8
—
—
—
0
0
5
9
6.01
2.26
1.4
1.0
—
—
—
0
0
10
39
2.94
2.08
1.2
1.4
—
—
—
0
0
7
25
3.08
1.72
1.7
1.2
—
—
—
0
0
6
20
3.26
1.63
5.5
2.8
0.45
0.74
%
—
6
20
6
21
3.10
1.55
2.2
2.2
—
—
—
0
0
6
21
3.10
1.55
5.5
2.7
1.30
1.46
%
—
6
21
26
178
1.94
1.47
8.3
6.1
—
—
—
0
0
9
41
2.45
1.46
1.8
1.4
—
—
—
0
0
11
55
2.27
1.40
2.5
2.5
0.80
0.81
mmol/l
0.07
11
50
21
136
1.93
1.38
2.4
4.1
65.15
63.78
ng/l
0.01
13
98
23
154
1.90
1.37
2.2
1.9
90.32
92.88
pmol/l
0.10
12
74
6
25
2.58
1.28
3.8
3.3
124.00
125.76
g/l
—
6
25
6
25
2.58
1.28
2.3
1.5
83.43
78.75
e9/l
—
6
19
5
19
2.80
1.24
4.8
1.5
—
—
—
0
0
7
30
2.54
1.18
1.3
1.0
—
—
—
0
0
11
60
2.06
1.13
1.9
2.2
—
—
—
0
0
7
32
2.37
1.13
5.3
3.2
5.74
5.71
kpa
—
7
32
7
34
2.22
1.08
5.3
3.2
—
—
—
0
0
5
22
2.41
1.06
5.0
9.3
—
0.00
—
0
6
5
22
2.41
1.06
4.2
3.0
23.16
24.66
mmol/l
—
5
22
16
103
1.81
1.03
7.2
2.5
58.25
54.04
u/l
0.22
16
97
9
51
1.93
1.01
1.2
1.2
—
—
—
0
0
15
98
1.75
0.91
4.5
4.0
—
—
—
0
0
6
30
2.13
0.90
6.0
3.1
4.43
3.75
kpa
—
6
30
0
25
0.00
0.81
0.0
1.1
—
—
—
0
0
5
23
2.30
0.78
5.0
8.9
—
0.63
—
0
8
5
23
2.30
0.78
2.6
5.1
—
—
—
0
0
5
27
1.94
0.70
3.4
3.4
—
—
—
0
0
11
71
1.70
0.69
1.6
1.1
2.11
2.37
g/l
—
6
40
32
270
1.50
0.63
4.3
4.4
—
—
—
0
0
19
240
0.67
0.63
3.7
3.8
—
—
—
0
0
0
22
0.00
0.61
0.0
1.5
—
—
—
0
0
41
366
1.61
0.60
23.2
16.6
140.15
139.47
mmol/l
1.63
41
355
41
367
1.60
0.58
23.2
16.6
3.93
3.95
mmol/l
0.20
41
355
7
45
1.64
0.51
1.3
1.7
—
—
—
0
0
12
87
1.50
0.47
1.9
1.6
0.65
1.02
mg/l
—
7
68
8
112
0.66
0.43
4.9
3.0
—
—
—
0
0
29
327
0.74
0.42
19.3
17.1
16.04
14.82
%
0.52
29
320
0
16
0.00
0.42
0.0
3.3
—
64.31
—
0
16
5
34
1.52
0.41
6.0
2.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
9
67
1.42
0.41
2.0
1.6
—
—
—
0
0
23
266
0.75
0.38
5.1
4.7
—
11141.20
—
0
5
6
41
1.52
0.38
1.3
1.4
—
—
—
0
0
6
87
0.65
0.37
3.7
2.7
7.67
4.81
e6/l
—
6
78
6
44
1.41
0.36
1.2
1.3
—
—
—
0
0
13
102
1.37
0.34
4.9
4.2
—
—
—
0
0
10
75
1.41
0.33
2.2
1.9
—
—
—
0
0
41
382
1.37
0.31
23.7
16.8
74.85
71.94
umol/l
0.40
41
382
5
38
1.35
0.24
1.4
2.0
—
—
—
0
0
5
38
1.35
0.24
2.6
1.2
—
—
—
0
0
19
166
1.23
0.22
2.3
2.0
—
—
—
0
0
12
99
1.28
0.22
1.9
2.5
40458.58
10171.98
umol/l
0.33
12
84
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
2.1
—
0.11
—
0
6
13
110
1.24
0.19
4.5
4.1
—
—
—
0
0
16
140
1.21
0.18
3.8
3.0
—
—
—
0
0
8
97
0.79
0.15
10.8
7.8
—
—
—
0
0
15
133
1.18
0.14
2.5
2.2
—
—
—
0
0
6
57
1.06
0.09
4.0
1.4
28.03
30.69
s
—
6
52
10
88
1.17
0.09
8.8
3.9
—
—
—
0
0
11
99
1.14
0.07
1.3
1.5
—
—
—
0
0
31
311
0.99
0.00
31.0
17.9
328.32
330.18
g/l
0.51
31
306
14
135
1.05
0.00
3.0
2.7
—
—
—
0
0
41
412
0.98
0.00
35.0
20.7
4.31
4.38
e12/l
0.45
41
395
41
412
0.98
0.00
35.1
20.8
127.90
131.43
g/l
0.95
41
405
41
412
0.98
0.00
34.6
20.6
6.74
6.64
e9/l
0.11
41
397
41
412
0.98
0.00
34.5
20.6
29.84
30.21
pg
0.78
41
404
41
412
0.98
0.00
34.7
20.7
275.54
255.29
e9/l
0.91
41
402
41
412
0.98
0.00
34.5
20.6
90.66
91.29
fl
0.44
41
404
20
198
1.02
0.00
4.8
5.3
13.20
11.43
umol/l
0.21
20
184
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
89.45
—
0
8
0
5
0.00
-0.00
0.0
11.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
10.50
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.8
—
4.93
—
0
9
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.8
—
9.49
—
0
9
0
9
0.00
-0.00
0.0
2.8
—
7.44
—
0
9
0
7
0.00
-0.00
0.0
1.7
—
60.14
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
8
84
0.94
-0.00
2.1
3.3
661.25
522.44
mosm/kgh2o
—
8
71
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
31.80
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.0
—
—
—
0
0
39
390
1.00
-0.00
24.4
12.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint E4_ATROTHY and mortality.

Females

Parameter HR [95% CI] p-value
E4_ATROTHY 1.365 [0.88, 2.11] 0.16
Birth year 1.0 [0.99, 1.01] 0.991

During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 182 females with E4_ATROTHY died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_ATROTHY.

N-year risk Females Males
1 0.137% No data
5 0.83% No data
10 1.972% No data
15 4.112% No data
20 7.823% No data

Relationships between endpoints

Index endpoint: E4_ATROTHY – Atrophy of thyroid (acquired)

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data